Pharmaceutical manufacturers are using AI tools and robots to speed up drug development and handle mundane lab tasks ...

OpenAI has met with the FDA to discuss using AI to speed up drug evaluations, part of the agency’s broader push to adopt AI ...

The government held a consultative meeting with private sector stakeholders Thursday to promote the use of artificial ...

As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

When it comes to training artificial intelligence, OpenAI and Babylon Biosciences have shown that experienced hands can help ...

Experts predicted that artificial intelligence would steal radiology jobs. But at the Mayo Clinic, the technology has been ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to ...

Nabla Bio's latest AI model update generates de novo antibodies for GPCRs with therapeutic-grade properties within a few ...